tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Neuraxis reports Q2 EPS (22c) vs. (42c) last year
PremiumThe FlyNeuraxis reports Q2 EPS (22c) vs. (42c) last year
3M ago
Is NRXS a Buy, Before Earnings?
Premium
Pre-Earnings
Is NRXS a Buy, Before Earnings?
3M ago
NeurAxis, Inc. Ends Agreement with Masimo Corporation
Premium
Company Announcements
NeurAxis, Inc. Ends Agreement with Masimo Corporation
4M ago
Neuraxis secures key academic society guidelines recommendation for FAP
PremiumThe FlyNeuraxis secures key academic society guidelines recommendation for FAP
5M ago
NeurAxis, Inc. Approves Key Proposals at Annual Meeting
Premium
Company Announcements
NeurAxis, Inc. Approves Key Proposals at Annual Meeting
5M ago
NeurAxis, Inc. Releases Investor Presentation
Premium
Company Announcements
NeurAxis, Inc. Releases Investor Presentation
5M ago
Neuraxis prices 1.54M shares at $3.25 in registered direct offering
PremiumThe FlyNeuraxis prices 1.54M shares at $3.25 in registered direct offering
5M ago
Neuraxis awarded FDA clearance for treatment of pediatric FAP, FD symptoms
Premium
The Fly
Neuraxis awarded FDA clearance for treatment of pediatric FAP, FD symptoms
5M ago
NeurAxis, Inc. Reports Increased Sales Amidst Losses
Premium
Company Announcements
NeurAxis, Inc. Reports Increased Sales Amidst Losses
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100